Marbls mobile app allows pharmaceutical manufacturers to comply with their obligations which can be complex and varied, it enables the general population to be better informed very easily on what U.S. states are attempting to do as it relates to support drug price transparency, and ultimately looks to better support the healthcare system.
Users can find detailed information on specific reporting and submission requirements in each state as well as information on requirements that may be forthcoming.
Reporting criteria often have varying submission frequencies (quarterly, annually), require submission to different entities (health departments, attorney generals, insurance commissioners), etc.
The app enables analysts and manufacturers to access all current and upcoming business reporting requirements in one place.
The rising cost of prescription drugs has prompted many states to create legislation aimed at increasing drug price transparency.